The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Aldosterone and parathyroid hormone interactions as mediators of metabolic and cardiovascular disease
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
European Guidelines on cardiovascular disease prevention in clinical practice (version 2012)
Authors/Task Force Members:, Perk, J., De Backer, G., Gohlke, H., Graham, I., Reiner, Ž., Verschuren, M., Albus, C., Benlian, P., Boysen, G., et al. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs092 · Cited by 8,490
Suppression of Aging in Mice by the Hormone Klotho
Kurosu, H., Yamamoto, M., Clark, J. D., Pastor, J. V., Nandi, A., Gurnani, P., McGuinness, O. P., Chikuda, H., Yamaguchi, M., Kawaguchi, H., et al. (2005) · Science · doi:10.1126/science.1112766 · Cited by 1,935
1,25-Dihydroxyvitamin D3 is a negative endocrine regulator of the renin-angiotensin system
Li, Y. C., Kong, J., Wei, M., Chen, Z.-F., Liu, S. Q., & Cao, L.-P. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215219 · Cited by 1,625 · cited 2×
“documented markedly elevated renin mRNA expression in the juxtaglomerular apparatus of vitamin D receptor (VDR) knock-out mice compared to wild type mice [41].”
BackgroundA prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients
Rossi, G. P., Bernini, G., Caliumi, C., Desideri, G., Fabris, B., Ferri, C., Ganzaroli, C., Giacchetti, G., Letizia, C., Maccario, M., et al. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.07.059 · Cited by 1,467
Control of aldosterone secretion: a model for convergence in cellular signaling pathways
SPÄT, A., & HUNYADY, L. (2004) · Physiological Reviews · doi:10.1152/physrev.00030.2003 · Cited by 494
Plasma Parathyroid Hormone and the Risk of Cardiovascular Mortality in the Community
Hagström, E., Hellman, P., Larsson, T. E., Ingelsson, E., Berglund, L., Sundström, J., Melhus, H., Held, C., Lind, L., Michaëlsson, K., et al. (2009) · Circulation · doi:10.1161/circulationaha.108.808733 · Cited by 416
Prevalence and Characteristics of the Metabolic Syndrome in Primary Aldosteronism
Fallo, F., Veglio, F., Bertello, C., Sonino, N., Della Mea, P., Ermani, M., Rabbia, F., Federspil, G., & Mulatero, P. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1733 · Cited by 372 · cited 1×
“[79] Fallo F,Veglio F, Bertello C, et al.”
Sowers, J. R., Whaley-Connell, A., & Epstein, M. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-150-11-200906020-00005 · Cited by 351
de Borst, M. H., Vervloet, M. G., ter Wee, P. M., & Navis, G. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010121251 · Cited by 282 · cited 3×
“[39] de Borst MH, Vervloet MG, ter Wee PM, Navis G.”
BackgroundVaidya, A., & Williams, J. S. (2012) · Metabolism · doi:10.1016/j.metabol.2011.09.007 · Cited by 151
PTH and PTH-related peptide enhance steroid secretion from human adrenocortical cells
Mazzocchi, G., Aragona, F., Malendowicz, L. K., & Nussdorfer, G. G. (2001) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2001.280.2.e209 · Cited by 123
Pilz, S., Kienreich, K., Drechsler, C., Ritz, E., Fahrleitner-Pammer, A., Gaksch, M., Meinitzer, A., März, W., Pieber, T. R., & Tomaschitz, A. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-2183 · Cited by 118
Self-citationCalcium metabolism and parathyroid function in primary aldosteronism
Resnick, L. M., & Laragh, J. H. (1985) · The American Journal of Medicine · doi:10.1016/0002-9343(85)90328-6 · Cited by 111 · cited 1×
“This research group had observed a remarkable elevation of PTH levels in the majority of patients with PA [121].”
BackgroundBone involvement in aldosteronism
Salcuni, A. S., Palmieri, S., Carnevale, V., Morelli, V., Battista, C., Guarnieri, V., Guglielmi, G., Desina, G., Eller-Vainicher, C., Beck-Peccoz, P., et al. (2012) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.1660 · Cited by 101
Primary Hyperparathyroidism With Concurrent Primary Aldosteronism
Maniero, C., Fassina, A., Guzzardo, V., Lenzini, L., Amadori, G., Pelizzo, M. R., Gomez-Sanchez, C., & Rossi, G. P. (2011) · Hypertension · doi:10.1161/hypertensionaha.111.173948 · Cited by 94
Vaidya, A., Forman, J. P., Hopkins, P. N., Seely, E. W., & Williams, J. S. (2011) · Journal of the Renin-Angiotensin-Aldosterone System · doi:10.1177/1470320310391922 · Cited by 93 · cited 2×
“[54] Vaidya A, Forman JP, Hopkins PN, et al.”
BackgroundMild hyperparathyroidism: a novel surgically correctable feature of primary aldosteronism
Maniero, C., Fassina, A., Seccia, T. M., Toniato, A., Iacobone, M., Plebani, M., De Caro, R., Calò, L. A., Pessina, A. C., & Rossi, G. P. (2012) · Journal of Hypertension · doi:10.1097/hjh.0b013e32834f0451 · Cited by 87
Brunaud, L., Germain, A., Zarnegar, R., Rancier, M., Alrasheedi, S., Caillard, C., Ayav, A., Weryha, G., Mirallie, E., & Bresler, L. (2009) · Surgery · doi:10.1016/j.surg.2009.09.041 · Cited by 83 · cited 3×
“[88] Brunaud L, Germain A, Zarnegar R, et al.”
BackgroundFracture Risk in Men With Congestive Heart Failure
Carbone, L. D., Cross, J. D., Raza, S. H., Bush, A. J., Sepanski, R. J., Dhawan, S., Khan, B. Q., Gupta, M., Ahmad, K., Khouzam, R. N., et al. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.03.039 · Cited by 79
Rossi, G. P., Ragazzo, F., Seccia, T. M., Maniero, C., Barisa, M., Calò, L. A., Frigo, A. C., Fassina, A., & Pessina, A. C. (2012) · Hypertension · doi:10.1161/hypertensionaha.112.195891 · Cited by 76 · cited 2×
“Recently, it has been evaluated whether serum PTH helps in differentiating between PA resulting from aldosterone producing adenomas or PA resulting from bilateral adrenal hyperplasia [128].”
BackgroundISALES, C. M., BARRETT, P. Q., BRINES, M., BOLLAG, W., & RASMUSSEN, H. (1991) · Endocrinology · doi:10.1210/endo-129-1-489 · Cited by 72
Vaidya, A., Sun, B., Larson, C., Forman, J. P., & Williams, J. S. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1156 · Cited by 68
Kovacs, L., Goth, M., Szabolcs, I., Dohan, O., Ferencz, A., & Szilagyi, G. (1998) · European Journal of Endocrinology · doi:10.1530/eje.0.1380543 · Cited by 66
Tomaschitz, A., Pilz, S., Ritz, E., Morganti, A., Grammer, T., Amrein, K., Boehm, B. O., & Marz, W. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehr150 · Cited by 64 · cited 2×
“The modulatory effects of vitamin D on the RAS might result in a lower risk of development and progression of CV morbidity and mortality [40,44].”
BackgroundSelf-citationSerum Parathyroid Hormone in Relation to All-Cause and Cardiovascular Mortality: The Hoorn Study
van Ballegooijen, A. J., Reinders, I., Visser, M., Dekker, J. M., Nijpels, G., Stehouwer, C. D. A., Pilz, S., & Brouwer, I. A. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-4007 · Cited by 62
Self-citationVaidya, A., Sun, B., Forman, J. P., Hopkins, P. N., Brown, N. J., Kolatkar, N. S., Williams, G. H., & Williams, J. S. (2011) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2011.03991.x · Cited by 58
Response of adrenal cells to parathyroid hormone stimulation
Rosenberg, J., Pines, M., & Hurwitz, S. (1987) · Journal of Endocrinology · doi:10.1677/joe.0.1120431 · Cited by 53 · cited 1×
“The authors identified the adrenal gland as a novel target for PTH [70].”
BackgroundAtchison, D. K., Harding, P., & Beierwaltes, W. H. (2011) · Hypertension · doi:10.1161/hypertensionaha.111.172890 · Cited by 26 · cited 2×
“[113] Atchison DK, Harding P, Beierwaltes WH.”
BackgroundAdrenal responses to subtotal parathyroidectomy for primary hyperparathyroidism
Pacifici, R., Perry, H. M., Shieber, W., Biglieri, E., Droke, D. M., & Avioli, L. V. (1987) · Calcified Tissue International · doi:10.1007/bf02563790 · Cited by 19 · cited 2×
“[85] Pacifici R, Perry 3rd HM, Shieber W, et al.”
BackgroundInfluence of renin–angiotensin system on serum parathyroid hormone levels in uremic patients
Koiwa, F., Komukai, D., Hirose, M., Yoshimura, A., Ando, R., Sakaguchi, T., Komatsu, Y., Shinoda, T., Inaguma, D., Joki, N., et al. (2012) · Clinical and Experimental Nephrology · doi:10.1007/s10157-011-0534-x · Cited by 17 · cited 2×
“documented in hemodialysis Japanese patients a decline of iPTH levels in parallel with the administration of RAS inhibitors independent of serum calcium levels [92].”
BackgroundCirculating aldosterone and mortality in female nursing home residents
Tomaschitz, A., Pilz, S., Pieske, B., Ritz, E., März, W., Meinitzer, A., Dobnig, H., Amrein, K., Kienreich, K., Verheyen, N., et al. (2013) · Experimental Gerontology · doi:10.1016/j.exger.2013.01.004 · Cited by 7 · cited 1×
“[16] Tomaschitz A, Pilz S, Pieske B, et al.”
BackgroundSelf-citation
Cited by
Diagnosis and treatment of primary aldosteronism
Reincke, M., Bancos, I., Mulatero, P., Scholl, U. I., Stowasser, M., & Williams, T. A. (2021) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(21)00210-2 · Cited by 354
Vitamin D and cardiovascular disease prevention
Pilz, S., Verheyen, N., Grübler, M. R., Tomaschitz, A., & März, W. (2016) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2016.73 · Cited by 326
Self-citationKhundmiri, S. J., Murray, R. D., & Lederer, E. (2016) · Comprehensive Physiology · doi:10.1002/cphy.c140071 · Cited by 296
Cardiovascular manifestations of primary hyperparathyroidism: a narrative review
Pepe, J., Cipriani, C., Sonato, C., Raimo, O., Biamonte, F., & Minisola, S. (2017) · European Journal of Endocrinology · doi:10.1530/eje-17-0485 · Cited by 165
Beysel, S., Caliskan, M., Kizilgul, M., Apaydin, M., Kan, S., Ozbek, M., & Cakal, E. (2019) · BMC Cardiovascular Disorders · doi:10.1186/s12872-019-1093-4 · Cited by 95
Metadata
- Authors
- Tomaschitz, A., Ritz, E., Pieske, B., Rus-Machan, J., Kienreich, K., Verheyen, N., Gaksch, M., Grübler, M., Fahrleitner-Pammer, A., Mrak, P., Toplak, H., Kraigher-Krainer, E., März, W., & Pilz, S.
- Venue
- Metabolism
- Publisher
- Elsevier BV
- Published
- 2014-01
- Volume
- 63
- Issue
- 1
- Pages
- 20-31
- ISSN
- 0026-0495 (ISSN-L)
- OpenAlex
- W2109509624
- Cited by
- 166
- References
- 31
- FWCI
- 11.79
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.